Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders

NCT05154734 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

NMO Spectrum Disorder

Interventions

DRUG: Belimumab

Sponsor

Tianjin Medical University General Hospital

Collaborators

[object Object]